Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.

Clinical trial NCT03402815 · COMPLETED

Trial details

NCT number: NCT03402815
Sponsor: University Of Perugia
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Infection With Other Conditions Cardiovascular Risk Factor Atherosclerosis Inflammation

Start date: 2015-01-01
Primary completion: 2017-04-30
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.